Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Conditions
Ewing Sarcoma · Colorectal Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
HonorHealth Research Institute, Scottsdale, Arizona, United States
Precision NextGen Oncology and Research, Beverly Hills, California, United States
Contact: Principal Investigator (Kamalesh Sankhala, MD)City of Hope, Duarte, California, United States
Contact: Study coordinator (New Patient Services Coordinator) · newpatientref@coh.org · 1-800-826-4673Contact: Principal Investigator (Marwan Fakih, MD)Valkyrie Clinical Trials, Los Angeles, California, United States
Contact: Principal Investigator (David Berz, MD)University of California, San Diego (UCSD) - Moores Cancer Center, San Diego, California, United States
University of California, San Francisco (UCSF), San Francisco, California, United States
Contact: Principal Investigator (Varun Monga, MD)Sarcoma Oncology Center, Santa Monica, California, United States
Contact: Principal Investigator (Sant P Chawla, MD)University of Colorado Hospital, Aurora, Colorado, United States
Contact: Principal Investigator (Christopher Lieu, MD)Emory University - Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Olatunji Alese, MD)The University of Chicago, Chicago, Illinois, United States
University of Michigan, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Rashmi Chugh, MD)START Midwest Michigan, PC, Grand Rapids, Michigan, United States
Contact: Principal Investigator (Nehal Lakhani, MD)David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Emily Slotkin, MD)Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Michael D Deel, MD)Cleveland Clinic, Cleveland, Ohio, United States
Oregon Health & Science University, Portland, Oregon, United States
Contact: Principal Investigator (Michael Heinrich, MD)Children's Hospital of Philadelphia- Center for Childhood Cancer Research, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Theodore Laetsch, MD)University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Lee Hartner, MD)Vanderbilt University School of Medicine, Nashville, Tennessee, United States
Contact: Principal Investigator (Elizabeth Davis, MD)UT MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (David Hong, MD)NEXT Oncology, San Antonio, Texas, United States
University of Virginia, Charlottesville, Virginia, United States
Contact: Principal Investigator (Ludimila Cavalcante, MD)NEXT Oncology - Virginia, Fairfax, Virginia, United States
Contact: Principal Investigator (Alexander Spira, MD)Centre Leon Berard, Lyon, France
Contact: Principal Investigator (Mehdi Brahmi, MD)Gustave Roussy, Villejuif, France
Contact: Principal Investigator (Pablo Berlanga, MD)La Fondazione e l'Istituto di Candiolo, Candiolo, Italy
Contact: Principal Investigator (Sandra Aliberti, MD)Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Contact: Principal Investigator (Salvatore Provenzano, MD)Contact: Principal Investigator (Roberto Luksch, MD)University Medical Center Groningen, Groningen, Netherlands
Contact: Principal Investigator (Jacco de Haan, MD)Academisch Ziekenhuis Leiden, Leiden, Netherlands
Contact: Principal Investigator (André (Hans) Gelderblom, MD)Hospital Universitario Vall d'Hebron, Barcelona, Spain
Contact: Principal Investigator (Elena Elez, MD)Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Contact: Principal Investigator (Ana Sebio Garcia, MD)Hospital Clinico San Carlos, Madrid, Spain
Contact: Principal Investigator (Antonio Casado Herraez)Great North Children's Hospital, London, United Kingdom
Contact: Principal Investigator (Quentin Campbell-Hewson, MD)University College London Hospital, London, United Kingdom
Contact: Principal Investigator (Sandra Strauss, MD)The Royal Marsden NHS Foundation Trust, London, United Kingdom
Contact: Principal Investigator (Andrea Napolitano, MD)Royal Manchester Children's Hospital, Manchester, United Kingdom
Contact: Principal Investigator (Bernadette Maria Dymphna Brennan)
Study leads
Clinical Lead
Study Director
Inhibrx Biosciences, Inc